mathew
in the last 3 or 4 cc's rosa had top surgeons/investigators with him in the call + the investigator meeting they had even with the trial halt was attended by alot of surgeons. so your comment " sold a bill goods by rosa " is way off target.
the whole issue with slow enrollment is broken down into 2 scenarios . most patients in this segment of the market believe they are not that sick to have a device . 2 , the cpulse is good , but why not wait for the fully implantable. which explains the slow enrollment and the change of the trial as we are seeing now.
I could list all the positives that were done by the previous management team in the last 5 years , and trust me the positives greatly outweigh the negatives. Reality is , the stock price when its this slow blinds alot of people.
as it seems like you have no faith in the product or the potential or the management , why hold on even to recoup losses. sell and save whatever you have left. your money but i dont understand your extreme negativity.
hell , id literally buy all your shares today for $1 , 40-50% premium just so i stop reading these comments here and on yahoo.
- Forums
- ASX - By Stock
- SHC
- Poison Pill
Poison Pill, page-7
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online